Cas 1292825-35-4,N,N-(carbonylbis(4,1-phenylene))bis(4-(dimethylamino)benzamide)

1292825-35-4

Post Buying Request

Basic information

Product Name: N,N-(carbonylbis(4,1-phenylene))bis(4-(dimethylamino)benzamide)
Synonyms: N,N-(carbonylbis(4,1-phenylene))bis(4-(dimethylamino)benzamide)
CAS NO:1292825-35-4
Molecular Formula:
Molecular Weight: 506.604
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N,N-(carbonylbis(4,1-phenylene))bis(4-(dimethylamino)benzamide)(CAS DataBase Reference)
NIST Chemistry Reference: N,N-(carbonylbis(4,1-phenylene))bis(4-(dimethylamino)benzamide)(1292825-35-4)
EPA Substance Registry System: N,N-(carbonylbis(4,1-phenylene))bis(4-(dimethylamino)benzamide)(1292825-35-4)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1292825-35-4(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1292825-35-4 Suppliers

Recommended suppliers

1292825-35-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1292825-35-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,9,2,8,2 and 5 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1292825-35:
(9*1)+(8*2)+(7*9)+(6*2)+(5*8)+(4*2)+(3*5)+(2*3)+(1*5)=174
174 % 10 = 4
So 1292825-35-4 is a valid CAS Registry Number.

1292825-35-4Upstream product

1292825-35-4Downstream Products

1292825-35-4Relevant academic research and scientific papers

HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES

-

Page/Page column 194-195, (2011/05/05)

The present embodiments relate to compounds with physiological effects, such as the activation of hematopoietic growth factor receptors. The present embodiments also relate to use of the compounds to treat a variety of conditions, diseases and ailments such as hematopoietic conditions and disorders.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1292825-35-4